Liver Cancer Therapeutics Market Analysis

The market is segmented by type into hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and others, out of which, the hepatocellular carcinoma segment is anticipated to hold the largest market share owing to being the most common type of liver cancer and is caused mainly due to alcohol abuse.

On the basis of therapy, the liver cancer therapeutics market is segmented into targeted therapy, radiation therapy, immunotherapy, chemotherapy, and others. Targeted therapy eliminates the side effects associated with other cancer therapies and targeted therapy drugs are largely recommended by healthcare providers. Owing to these factors, the targeted therapy segment is estimated to grow at the highest rate over the forecast period. Furthermore, there are various targeted therapy clinical trials that are ongoing, while several are getting approved as treatment methods rapidly. These factors are further expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments: